Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 61

1.

CD40L induces functional tunneling nanotube networks exclusively in dendritic cells programmed by mediators of type 1 immunity.

Zaccard CR, Watkins SC, Kalinski P, Fecek RJ, Yates AL, Salter RD, Ayyavoo V, Rinaldo CR, Mailliard RB.

J Immunol. 2015 Feb 1;194(3):1047-56. doi: 10.4049/jimmunol.1401832. Epub 2014 Dec 29.

PMID:
25548234
2.

Transcriptional Regulation of CXCL5 in HIV-1-Infected Macrophages and Its Functional Consequences on CNS Pathology.

Guha D, Klamar CR, Reinhart T, Ayyavoo V.

J Interferon Cytokine Res. 2015 May;35(5):373-84. doi: 10.1089/jir.2014.0135. Epub 2014 Dec 23.

PMID:
25536401
3.

HIV's ticket to ride: Cytotoxic T-lymphocyte-activated dendritic cells exploited for virus intercellular transfer.

Zaccard CR, Watkins SC, Ayyavoo V, Rinaldo CR, Mailliard RB.

AIDS Res Hum Retroviruses. 2014 Nov;30(11):1023-4. doi: 10.1089/aid.2014.0218. No abstract available.

PMID:
25354022
4.

Nanotechnology-based approaches for the development of diagnostics, therapeutics, and vaccines.

Srinivasan A, Rastogi A, Ayyavoo V, Srivastava S.

Monoclon Antib Immunodiagn Immunother. 2014 Jun;33(3):186-91. doi: 10.1089/mab.2014.0045. Review.

PMID:
24937250
5.

Serum microRNAs in HIV-infected individuals as pre-diagnosis biomarkers for AIDS-NHL.

Thapa DR, Hussain SK, Tran WC, Dʼsouza G, Bream JH, Achenback CJ, Ayyavoo V, Detels R, Martínez-Maza O.

J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):229-37. doi: 10.1097/QAI.0000000000000146.

PMID:
24675587
6.

Human immunodeficiency virus type 1 Vpr polymorphisms associated with progressor and nonprogressor individuals alter Vpr-associated functions.

Hadi K, Walker LA, Guha D, Murali R, Watkins SC, Tarwater P, Srinivasan A, Ayyavoo V.

J Gen Virol. 2014 Mar;95(Pt 3):700-11. doi: 10.1099/vir.0.059576-0. Epub 2013 Dec 3.

7.

Innate immune evasion strategies by human immunodeficiency virus type 1.

Guha D, Ayyavoo V.

ISRN AIDS. 2013 Aug 12;2013:954806. doi: 10.1155/2013/954806. Review.

8.

Development of a robust cell-based high-throughput screening assay to identify targets of HIV-1 viral protein R dimerization.

Zych C, Domling A, Ayyavoo V.

Drug Des Devel Ther. 2013 May 24;7:403-12. doi: 10.2147/DDDT.S44139. Print 2013.

9.

MicroRNA regulation and its effects on cellular transcriptome in human immunodeficiency virus-1 (HIV-1) infected individuals with distinct viral load and CD4 cell counts.

Duskova K, Nagilla P, Le HS, Iyer P, Thalamuthu A, Martinson J, Bar-Joseph Z, Buchanan W, Rinaldo C, Ayyavoo V.

BMC Infect Dis. 2013 May 30;13:250. doi: 10.1186/1471-2334-13-250.

10.

Neuronal apoptosis by HIV-1 Vpr: contribution of proinflammatory molecular networks from infected target cells.

Guha D, Nagilla P, Redinger C, Srinivasan A, Schatten GP, Ayyavoo V.

J Neuroinflammation. 2012 Jun 22;9:138. doi: 10.1186/1742-2094-9-138.

11.

Retrocyclin RC-101 blocks HIV-1 transmission across cervical mucosa in an organ culture.

Gupta P, Ratner D, Ding M, Patterson B, Rohan LC, Reinhart TA, Ayyavoo V, Huang X, Patton DL, Ramratnam B, Cole AM.

J Acquir Immune Defic Syndr. 2012 Aug 15;60(5):455-61.

12.

Gene array studies in HIV-1 infection.

Mehla R, Ayyavoo V.

Curr HIV/AIDS Rep. 2012 Mar;9(1):34-43. doi: 10.1007/s11904-011-0100-x. Review.

13.

Comparative expression profile of miRNA and mRNA in primary peripheral blood mononuclear cells infected with human immunodeficiency virus (HIV-1).

Gupta A, Nagilla P, Le HS, Bunney C, Zych C, Thalamuthu A, Bar-Joseph Z, Mathavan S, Ayyavoo V.

PLoS One. 2011;6(7):e22730. doi: 10.1371/journal.pone.0022730. Epub 2011 Jul 28. Retraction in: PLoS One. 2012;7(8). doi: 10.1371/annotation/d28d38b2-41a3-42a6-b421-68f9460a676d.

14.

Human immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particles.

Venkatachari NJ, Walker LA, Tastan O, Le T, Dempsey TM, Li Y, Yanamala N, Srinivasan A, Klein-Seetharaman J, Montelaro RC, Ayyavoo V.

Virol J. 2010 Jun 7;7:119. doi: 10.1186/1743-422X-7-119.

15.

Generation of robust CD8+ T-cell responses against subdominant epitopes in conserved regions of HIV-1 by repertoire mining with mimotopes.

Schaubert KL, Price DA, Salkowitz JR, Sewell AK, Sidney J, Asher TE, Blondelle SE, Adams S, Marincola FM, Joseph A, Sette A, Douek DC, Ayyavoo V, Storkus W, Leung MY, Ng HL, Yang OO, Goldstein H, Wilson DB, Kan-Mitchell J.

Eur J Immunol. 2010 Jul;40(7):1950-62. doi: 10.1002/eji.200940079.

16.

HIV-1 infection of DC: evidence for the acquisition of virus particles from infected T cells by antigen uptake mechanism.

Venkatachari NJ, Alber S, Watkins SC, Ayyavoo V.

PLoS One. 2009 Oct 15;4(10):e7470. doi: 10.1371/journal.pone.0007470.

17.

HIV-1 mediated immune pathogenesis: spotlight on the role of viral protein R (Vpr).

Majumder B, Venkatachari NJ, Srinivasan A, Ayyavoo V.

Curr HIV Res. 2009 Mar;7(2):169-77. Review.

PMID:
19275586
18.

A comprehensive analysis of the naturally occurring polymorphisms in HIV-1 Vpr: potential impact on CTL epitopes.

Srinivasan A, Ayyavoo V, Mahalingam S, Kannan A, Boyd A, Datta D, Kalyanaraman VS, Cristillo A, Collman RG, Morellet N, Sawaya BE, Murali R.

Virol J. 2008 Aug 23;5:99. doi: 10.1186/1743-422X-5-99.

19.

Human immunodeficiency virus (HIV-1) infection selectively downregulates PD-1 expression in infected cells and protects the cells from early apoptosis in vitro and in vivo.

Venkatachari NJ, Buchanan WG, Ayyavoo V.

Virology. 2008 Jun 20;376(1):140-53. doi: 10.1016/j.virol.2008.03.015. Epub 2008 Apr 25.

20.

Infection with Vpr-positive human immunodeficiency virus type 1 impairs NK cell function indirectly through cytokine dysregulation of infected target cells.

Majumder B, Venkatachari NJ, O'Leary S, Ayyavoo V.

J Virol. 2008 Jul;82(14):7189-200. doi: 10.1128/JVI.01979-07. Epub 2008 Apr 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk